These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2849636)

  • 1. Appearance of immune complexes during experimental hepatitis A infection in chimpanzees.
    Margolis HS; Nainan OV; Krawczynski K; Bradley DW; Ebert JW; Spelbring J; Fields HA; Maynard JE
    J Med Virol; 1988 Nov; 26(3):315-26. PubMed ID: 2849636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fulminant type A viral hepatitis in a chimpanzee.
    Abe K; Shikata T
    Acta Pathol Jpn; 1982 Jan; 32(1):143-8. PubMed ID: 7041511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of virus components in circulating immune complexes isolated during hepatitis A virus infection.
    Margolis HS; Nainan OV
    Hepatology; 1990 Jan; 11(1):31-7. PubMed ID: 1688544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental model of hepatitis A in rhesus monkeys (Macaca mulatta) infected with human hepatitis A virus].
    Shevtsova ZV; Krylova RI; Doroshenko NV; Lomovskaia IB; Belova EG; Zairov GK; Dzhelieva ZN; Lapin BA; Stakhanova VM
    Biull Eksp Biol Med; 1990 Jun; 109(6):536-9. PubMed ID: 2168770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of viremia in hepatitis A virus infection.
    Bower WA; Nainan OV; Han X; Margolis HS
    J Infect Dis; 2000 Jul; 182(1):12-7. PubMed ID: 10882576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation of hepatitis A virus antigen-anti-HAV antibody complexes by 2-mercaptoethanol and dithiothreitol.
    Bradley DW; McCaustland KA; Cook EH; Fields HA; Frosner GG; Maynard JE
    J Med Virol; 1982; 9(4):311-25. PubMed ID: 6286866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of acute phase anti-hepatitis A virus (HAV) IgM and development of an IgM solid-phase radioimmunoassay for the detection of HAV.
    Fields HA; McCaustland KA; Bradley DW; Maynard JE
    J Immunol Methods; 1982 Jun; 51(2):149-57. PubMed ID: 6286776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunoenzyme analysis of antigen-specific determination of HBsAG-containing circulating immune complexes (CIC HBsAG/IgM and CIC HBsAG/IgG) in blood serum of patients with HBV-infection].
    Sokolenko AA; Shakhanina KL; Kurilov AN
    Biull Eksp Biol Med; 1992 Feb; 113(2):174-6. PubMed ID: 1377044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental models of hepatitis A in macaques using viral strains isolated from man and monkeys].
    Korzaia LI; Esvandzhiia NCh; Lomovskaia IB; Krylova RI; Shevtsova ZV
    Mikrobiol Z; 1994; 56(1):22-9. PubMed ID: 8087252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific immunoglobulin M response to hepatitis A virus determined by solid-phase radioimmunoassay.
    Lemon SM; Brown CD; Brooks DS; Simms TE; Bancroft WH
    Infect Immun; 1980 Jun; 28(3):927-36. PubMed ID: 6249750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antibody response following hepatitis A infection.
    Locarnini SA; Ferris AA; Lehmann NI; Gust ID
    Intervirology; 1977; 8(5):309-18. PubMed ID: 195913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serodiagnosis of viral hepatitis A by a solid-phase radioimmunoassay specific for IgM antibodies.
    Hansson BG; Calhoun JK; Wong DC; Feinstone SM; Purcell RH; Pannuti CS; Pereira JL; Koff RS; Dienstag JL; Iwarson S
    Scand J Infect Dis; 1981; 13(1):5-9. PubMed ID: 6264589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of solid phase test systems for demonstrating antibodies against hepatitis A virus (anti-Hav) of the IgM-class.
    Roggendorf M; Frösner GG; Deinhardt F; Scheid R
    J Med Virol; 1980; 5(1):47-62. PubMed ID: 6247442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of IgM anti-hepatitis A antibodies by immunoenzyme technic. Interpretation of results and comparison of 2 tests (Havab-M EIA and Hepanostika anti-HAV IgM].
    Barin F; Lesage G; Dubois F; Yvonnet B; Coursaget P; Goudeau A
    Pathol Biol (Paris); 1983 Dec; 31(10):825-8. PubMed ID: 6322094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Circulating immune complexes in acute and prolonged hepatitis A infection].
    Dautović-Krkić S; Gribajcević M
    Med Arh; 2002; 56(3):143-6. PubMed ID: 12378858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Virus persistence in hepatitis A in monkeys].
    Shevtsova ZV; Lomovskaia IB; Lapin BA; Esvandzhiia NCh; D'iachenko AG
    Vopr Virusol; 1992; 37(3):138-41. PubMed ID: 1332264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis A virus infection: pathogenesis and serodiagnosis of acute disease.
    Bradley DW
    J Virol Methods; 1980 Dec; 2(1-2):31-45. PubMed ID: 6262342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased IgM class circulating immune complexes in acute hepatitis A virus infection.
    Tsai JF; Margolis HS; Jeng JE; Ho MS; Chang WY; Hsieh MY; Lin ZY; Tsai JH
    Clin Immunol Immunopathol; 1996 Mar; 78(3):291-5. PubMed ID: 8605705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of chemically aggregated IgM in an immunoglobulin class-specific immune complex assay.
    Margolis HS; Nainan OV; Fields HA; Bradley DW
    J Immunol Methods; 1987 Aug; 102(1):23-31. PubMed ID: 3305710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A "reverse" solid-phase radio-immuno-assay for IgM-antibodies to hepatitis A virus.
    Meurman OH; Matter L; Krishna RV; Krech UH
    Acta Pathol Microbiol Scand C; 1981 Apr; 89(2):79-84. PubMed ID: 6270954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.